| Differentiated Thyroid Gland Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 39show all (up to 200) |
|---|
| → investigated in trials for | Cabozantinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |